Shares of Nektar Therapeutics (NKTR) sunk on Friday morning after the company revealed in an earnings call Thursday night that there had been manufacturing issues in two batches of experimental cancer drugs Nektar gave to patients in a trial. EARNINGS: On Thursday… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id2949222/-Nektar-sinks-after-disclosing-string-of-negative-updates-with-Q-report)
next post